IRVINE, Calif.–(BUSINESS WIRE)–Jun. 13, 2016–
Masimo
(NASDAQ: MASI) announced today FDA 510(k) clearance for O3™ regional
oximetry. Regional oximetry, also referred to as tissue or cerebral
oximetry, may help clinicians monitor cerebral oxygenation in situations
in which pulse oximetry alone may not be fully indicative of the oxygen
in the brain due to various factors, such as the type of clinical
procedure being performed.

This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20160613005405/en/

Masimo Root with O3 Regional Oximetry and SedLine Brain Function Moni…

Más información: Masimo Announces 510(k) Clearance for O3™ Regional Oximetry